Please assess the completion status of the following clinical trial:

Trial Title: Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth Abrasion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Any patient falling within age group with granulation tissue around G tube site~Exclusion Criteria:~* Patients falling outside of age group range

- Gender: ALL
- Minimum Age: None
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Silver Nitrate (Type: ACTIVE_COMPARATOR): Silver Nitrate is supplied in the form of pre-packaged applicator sticks to parents and patients. The concentration is 75% Silver Nitrate and 25% Potassium Nitrate. Application will be done 3 times a week for a period of 3 weeks.
- Kenalog (Triamcinolone) (Type: ACTIVE_COMPARATOR): Kenalog is a topical corticosteroid that shares anti-inflammatory, anti-pruritic, and vasoconstrictive actions.The dosage of Kenalog used in the study is 0.5%. Application is topical, and the frequency is 3 times a day for the 3 week trial period. FDA approved use of Kenalog in the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It has not been studied whether Kenalog has any proven advantage over Silver nitrate in the treatment of granulation tissue, but it has been used for the treatment of granulation tissue at the gastrostomy site with good effect.
- Washcloth Abrasion (Type: ACTIVE_COMPARATOR): Washcloth abrasion will be done with regular soap and water applied to a washcloth. The granulation tissue will be gently washed and abraded once daily for three weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).